Noliprel A (Indapamide, Perindopril Arginine)

Noliprel A is used in the management of hypertension, a condition characterized by elevated systemic arterial pressure.

• Hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk.
• Essential hypertension: provides consistent blood pressure control when monotherapy is insufficient.
• High‑risk hypertensive patients: contributes to overall risk reduction for stroke and myocardial infarction.

• Indapamide acts on the distal renal tubule to inhibit sodium reabsorption, promoting diuresis and reducing plasma volume. Perindopril arginine blocks the angiotensin‑converting enzyme, decreasing formation of angiotensin II, which leads to vasodilation, reduced aldosterone secretion, and lowered systemic vascular resistance, together achieving blood pressure reduction.

Noliprel A may cause a range of adverse reactions, from mild to serious.

Common Side Effects

• Dizziness or light‑headedness
• Headache
• Persistent dry cough
• Fatigue or weakness
• Increased urination
• Electrolyte disturbances (e.g., low potassium)

Serious or Rare Side Effects

• Angioedema (swelling of face, lips, tongue)
• Severe hypotension
• Acute renal impairment
• Hyperkalemia
• Neutropenia or agranulocytosis
• Hepatic dysfunction

Before initiating Noliprel A, several safety considerations should be observed.

• Blood pressure monitoring: ensure adequate control and avoid excessive drops.
• Renal function assessment: check serum creatinine and eGFR regularly.
• Electrolyte balance: monitor potassium and sodium levels, especially in patients on other diuretics.
• Hepatic impairment: use caution in patients with severe liver disease.
• Diabetes management: watch for changes in blood glucose control.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Noliprel A can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid)

• Potassium‑sparing diuretics or supplements: risk of hyperkalemia.
• Aliskiren in diabetic patients: may cause renal dysfunction.
• Lithium: increased lithium levels and toxicity.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs): may blunt antihypertensive effect and impair renal function.
• Other ACE inhibitors or ARBs: additive risk of angioedema and hypotension.

Moderate Interactions (Monitor Closely)

• Other antihypertensives (beta‑blockers, calcium channel blockers): may require dose adjustment.
• Antidiabetic agents: possible enhancement of hypoglycaemic effect.
• High‑dose aspirin: may affect renal perfusion.
• Warfarin: potential alteration of INR values.
• Corticosteroids: may increase sodium retention and counteract diuretic effect.